Is the BCR-ABL/GUSB transcript level at diagnosis an early predictive marker for chronic myeloid leukemia patients treated with imatinib?

Spremljeno u:
Bibliografski detalji
Izdano u:Rev Bras Hematol Hemoter
Glavni autori: Bonecker, Simone, Magnago, Marina, Kaeda, Jaspal, Solza, Cristiana, Zalcberg Renault, Ilana
Format: Artigo
Jezik:Inglês
Izdano: Sociedade Brasileira de Hematologia e Hemoterapia 2015
Teme:
Letter to the Editor
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4382567/
https://ncbi.nlm.nih.gov/pubmed/25818829
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.bjhh.2014.08.003
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items